NASDAQ:LHCG - LHC Group Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $233.75
  • Forecasted Upside: 15.64 %
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$202.14
▲ +2.69 (1.35%)

This chart shows the closing price for LHCG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New LHC Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LHCG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LHCG

Analyst Price Target is $233.75
▲ +15.64% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for LHC Group in the last 3 months. The average price target is $233.75, with a high forecast of $260.00 and a low forecast of $190.00. The average price target represents a 15.64% upside from the last price of $202.14.

This chart shows the closing price for LHCG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 7 investment analysts is to buy stock in LHC Group. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/1/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/31/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/29/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/27/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/26/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/26/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/25/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/8/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$240.00 ➝ $260.00Medium
1/25/2021Credit Suisse GroupInitiated CoverageOutperform$255.00Low
1/5/2021TruistBoost Price Target$245.00 ➝ $260.00N/A
11/17/2020OppenheimerReiterated RatingBuyLow
11/5/2020OppenheimerBoost Price TargetOutperform$245.00 ➝ $250.00High
10/19/2020OppenheimerBoost Price TargetOutperform$233.00 ➝ $245.00Medium
8/12/2020UBS GroupDowngradeBuy ➝ Neutral$170.00 ➝ $210.00Low
8/11/2020StephensBoost Price TargetOverweight$200.00 ➝ $225.00High
7/9/2020SunTrust BanksBoost Price TargetBuy$200.00 ➝ $220.00Low
7/1/2020BenchmarkBoost Price TargetBuy$160.00 ➝ $190.00Medium
6/3/2020Deutsche Bank AktiengesellschaftBoost Price TargetPositive ➝ Buy$160.00 ➝ $165.00High
5/21/2020SunTrust BanksBoost Price TargetBuy$160.00 ➝ $200.00Medium
5/14/2020UBS GroupLower Price TargetBuy$179.00 ➝ $170.00Low
3/20/2020BenchmarkBoost Price TargetBuy$144.00 ➝ $160.00High
3/4/2020Royal Bank of CanadaReiterated RatingBuy$180.00Medium
3/2/2020StephensLower Price TargetOverweight$161.00 ➝ $150.00Medium
2/28/2020Robert W. BairdLower Price TargetNeutral$170.00 ➝ $150.00High
12/6/2019SunTrust BanksBoost Price TargetBuy$145.00 ➝ $160.00Low
11/7/2019William BlairReiterated RatingOutperformLow
10/21/2019StephensInitiated CoverageOverweight$132.00Low
9/23/2019UBS GroupBoost Price TargetBuy$133.00 ➝ $136.00Low
9/16/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$145.00Medium
8/9/2019Royal Bank of CanadaSet Price TargetBuy$135.00Medium
8/9/2019OppenheimerBoost Price TargetOutperform$125.00 ➝ $146.00Medium
8/9/2019BarclaysBoost Price TargetEqual Weight$113.00 ➝ $120.00Medium
5/13/2019Royal Bank of CanadaBoost Price TargetOutperform$130.00Low
5/12/2019BarclaysReiterated RatingNeutral ➝ HoldLow
5/10/2019UBS GroupSet Price TargetBuy$133.00Low
5/9/2019Jefferies Financial GroupBoost Price TargetBuy$125.00 ➝ $130.00High
3/21/2019BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$95.00 ➝ $104.00Low
3/4/2019Robert W. BairdBoost Price TargetNeutral ➝ Neutral$98.00 ➝ $120.00Low
3/1/2019SunTrust BanksBoost Price TargetBuy$130.00Low
3/1/2019Craig HallumBoost Price TargetHold$93.00 ➝ $114.00Low
12/14/2018BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$105.00High
11/15/2018UBS GroupInitiated CoverageBuy ➝ Buy$109.00High
11/2/2018Robert W. BairdBoost Price TargetNeutral ➝ Neutral$95.00 ➝ $98.00Low
11/1/2018William BlairReiterated RatingBuyHigh
10/26/2018Craig HallumDowngradeBuy ➝ Hold$99.00 ➝ $92.00High
9/18/2018Bank of AmericaSet Price TargetBuy$119.00Low
9/13/2018SunTrust BanksBoost Price TargetBuy$115.00Low
9/12/2018Cantor FitzgeraldInitiated CoverageOverweight$117.00Low
8/3/2018Royal Bank of CanadaBoost Price TargetSector Perform$101.00Medium
8/3/2018Jefferies Financial GroupBoost Price TargetBuy$120.00Medium
8/2/2018BenchmarkSet Price TargetBuy$110.00High
8/2/2018OppenheimerBoost Price TargetOutperform$85.00 ➝ $110.00High
5/6/2018William BlairReiterated RatingBuyMedium
4/4/2018Craig HallumBoost Price TargetBuy$70.00 ➝ $80.00High
4/4/2018Jefferies Financial GroupReiterated RatingBuy ➝ Buy$84.00High
3/2/2018StephensSet Price TargetBuy$74.00Low
12/7/2017OppenheimerReiterated RatingBuy$85.00Low
11/28/2017Robert W. BairdSet Price TargetHold$71.00Low
11/21/2017William BlairReiterated RatingOutperformN/A
11/17/2017OppenheimerBoost Price TargetOutperform$80.00 ➝ $85.00N/A
11/10/2017Robert W. BairdReiterated RatingHold$69.00N/A
11/7/2017OppenheimerBoost Price TargetOutperform$68.00 ➝ $80.00N/A
11/7/2017Craig HallumReiterated RatingBuy$67.00 ➝ $80.00N/A
11/7/2017Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$70.00 ➝ $81.00N/A
11/7/2017Jefferies Financial GroupBoost Price TargetHold ➝ Buy$68.00 ➝ $83.00N/A
11/3/2017SunTrust BanksReiterated RatingBuy$75.00N/A
9/12/2017Robert W. BairdReiterated RatingHold$63.00Low
9/6/2017Royal Bank of CanadaReiterated RatingBuy$70.00Low
8/21/2017Bank of AmericaInitiated CoverageBuy ➝ Buy$76.00Low
8/4/2017Jefferies Financial GroupReiterated RatingBuy$68.00Medium
7/18/2017Royal Bank of CanadaReiterated RatingBuy$69.00Low
6/13/2017Royal Bank of CanadaReiterated RatingBuyLow
6/9/2017Jefferies Financial GroupReiterated RatingBuy$65.00Low
6/8/2017BenchmarkBoost Price TargetBuy ➝ Buy$63.00 ➝ $72.00Medium
5/15/2017Royal Bank of CanadaReiterated RatingBuy$69.00N/A
5/15/2017Jefferies Financial GroupBoost Price TargetBuy$56.00 ➝ $65.00N/A
5/8/2017OppenheimerReiterated RatingOutperform$55.00 ➝ $68.00Low
5/6/2017StephensSet Price TargetBuy$69.00Low
5/5/2017Royal Bank of CanadaReiterated RatingBuy$69.00Low
5/5/2017Jefferies Financial GroupReiterated RatingBuy$56.00 ➝ $65.00Medium
3/11/2017Craig HallumSet Price TargetBuy$57.00High
3/10/2017Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$44.00 ➝ $58.00High
3/10/2017Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$44.00 ➝ $58.00High
3/10/2017SunTrust BanksUpgradeHold ➝ Buy$50.00 ➝ $56.00High
1/27/2017BenchmarkInitiated CoverageBuy$55.00N/A
12/16/2016Craig HallumInitiated CoverageBuy$50.00N/A
9/13/2016OppenheimerReiterated RatingOutperform$50.00 ➝ $46.00N/A
(Data available from 6/24/2016 forward)
LHC Group logo
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company's Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services. Its Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. The company's Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand services to patients in their home or in a medical facility. Its Facility-Based Services segment serves patients suffering from respiratory failure, neuromuscular and cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates institutional pharmacy and other non-related facilities, nursing facilities, family health center, rural health clinic, and physician practice, as well as offers physical therapy services. The company's Healthcare Innovations (HCI) Services segment provides strategic health management services to accountable care organizations. As of December 31, 2020, it operated 537 home health services locations, 120 hospice locations, 124 community-based service locations, 11 long-term acute care hospitals with 12 locations, and 12 HCI locations. The company was founded in 1994 and is based in Lafayette, Louisiana.
Read More

Today's Range

Now: $202.14
Low: $198.73
High: $202.21

50 Day Range

MA: $200.72
Low: $185.44
High: $219.09

52 Week Range

Now: $202.14
Low: $164.70
High: $236.81

Volume

88,515 shs

Average Volume

169,439 shs

Market Capitalization

$6.40 billion

P/E Ratio

51.05

Dividend Yield

N/A

Beta

0.41

Frequently Asked Questions

What sell-side analysts currently cover shares of LHC Group?

The following Wall Street sell-side analysts have issued research reports on LHC Group in the last year: Benchmark Co., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Oppenheimer Holdings Inc., Stephens, SunTrust Banks, Inc., Truist, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for LHCG.

What is the current price target for LHC Group?

8 Wall Street analysts have set twelve-month price targets for LHC Group in the last year. Their average twelve-month price target is $233.75, suggesting a possible upside of 17.2%. Deutsche Bank Aktiengesellschaft has the highest price target set, predicting LHCG will reach $260.00 in the next twelve months. Benchmark Co. has the lowest price target set, forecasting a price of $190.00 for LHC Group in the next year.
View the latest price targets for LHCG.

What is the current consensus analyst rating for LHC Group?

LHC Group currently has 1 hold rating and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe LHCG will outperform the market and that investors should add to their positions of LHC Group.
View the latest ratings for LHCG.

What other companies compete with LHC Group?

How do I contact LHC Group's investor relations team?

LHC Group's physical mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider's listed phone number is 337-233-1307 and its investor relations email address is [email protected] The official website for LHC Group is www.lhcgroup.com.